Paper32091025
Morphea: a practical review of its diagnosis, classification and treatment.
Rodríguez-Salgado P and 1 other. Gac Med Mex, 2019. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Morphea: a practical review of its diagnosis, classification and treatment. Papers, record 32091025. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32091025
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Scleroderma, Localized | Major topic |
| Exercise Therapy | |
| Female | |
| Humans | |
| Immunosuppressive Agents | |
| Male | |
| Phototherapy | |
| Prognosis | |
| Severity of Illness Index | |
| Sex Factors |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41960002 | Cervical Spine Involvement in Morphea Patients With Subclinical Neurologic Signs. | Cureus | 2026 | https://conductscience.org/library/papers/41960002 | PubMed |
| 41488763 | Combination of Oral Hydroxychloroquine and Topical Pimecrolimus 1% for Linear Morphea in Breastfeeding: A Rare Case with Favorable Outcome. | Int J Womens Health | 2025 | https://conductscience.org/library/papers/41488763 | PubMed |
| 41426854 | Advanced Diffuse Systemic Sclerosis With Progressive Esophageal Dysfunction: Clinical Challenges in a Public Hospital. | Cureus | 2025 | https://conductscience.org/library/papers/41426854 | PubMed |
| 40104082 | Association of Bullous Lichen Sclerosus and Morphea. | Clin Case Rep | 2025 | https://conductscience.org/library/papers/40104082 | PubMed |
| 39703729 | Pregnancy-Related Morphea: A Case Report. | Clin Med Insights Case Rep | 2024 | https://conductscience.org/library/papers/39703729 | PubMed |
| 39429426 | Calcium Hydroxyapatite as a Co-adjuvant Treatment Option in a Patient With Morphea: A Report of a Case With a One-Year Follow-Up. | Cureus | 2024 | https://conductscience.org/library/papers/39429426 | PubMed |
| 39259320 | Exploring the relationship between morphea and malignancy: a decade-long single-center study of 204 patients. | Arch Dermatol Res | 2024 | https://conductscience.org/library/papers/39259320 | PubMed |
| 38924131 | High-frequency ultrasound evaluation of morphea: Retrospective analytical study. | Skin Res Technol | 2024 | https://conductscience.org/library/papers/38924131 | PubMed |
| 37849593 | Limited Cutaneous Scleroderma: A Case Report. | Cureus | 2023 | https://conductscience.org/library/papers/37849593 | PubMed |
| 36320926 | Diagnosis and Management of Cutaneous Manifestations of Autoimmune Connective Tissue Diseases. | Clin Cosmet Investig Dermatol | 2022 | https://conductscience.org/library/papers/36320926 | PubMed |
| 34362192 | Laser Therapy for the Treatment of Morphea: A Systematic Review of Literature. | J Clin Med | 2021 | https://conductscience.org/library/papers/34362192 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32091025
GET https://conductscience.org/api/papers/v1/32091025/authors